Under the structure of the transaction, the aggregate investment amount will be up to $15 million invested in two tranches of $7.5 million each and divided among a group of institutional and accredited investors in varying percentages.
More Articles on Orthopedic Devices:
40 Orthopedic & Spine FDA 510(k) Device Clearances in July
Misonix Adds 6 Spine Sales Agencies
FDA Proposes New 510(k) Process to Ensure Application Completeness
